$1.2 Million Distributed by Mary Kay Ash Foundation Will Fund Promising Cancer Researchers at Top Universities Advancing Cures For Women-Related Cancers Dr. Howe, an assistant professor of ...

NORTH CHICAGO, Ill., June 25, 2025 /PRNewswire/ -- UP Oncolytics, a neuro-oncology biotechnology company based in Milwaukee and a spin-out of the Advocate Aurora Research Institute, has received a ...

NORTH CHICAGO, Ill., Oct. 23, 2024 /PRNewswire/ -- U.P. Oncolytics, a company in Rosalind Franklin University's Helix 51 biomedical incubator, has been awarded Orphan Drug designation by the FDA's ...

Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer.

Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer.

The company is also exploring its application in other cancer types. In early 2025, UP Oncolytics established and expanded its research laboratories at Rosalind Franklin University's Helix 51 ...

In early 2025, UP Oncolytics established and expanded its research laboratories at Rosalind Franklin University's Helix 51 biomedical incubator. Under the leadership of Dr. Parvez Akhtar, chief ...